Lipitor Type 2 Diabetes Litigation Heating up

Countless people who took Lipitor (Atorvastatin) and were later diagnosed with type 2 diabetes are seeking to hold Pfizer and its distributors responsible.  In California, cases filed throughout the State have been coordinated before Judge Jane Johnson in Los Angeles with an initial status conference held on February 25, 2014. (See JCCP 4761). Judge Johnson [...]

March 5th, 2014|Drug and Medical Device Litigation, Lipitor|0 Comments

Pfizer’s Lipitor Faces Colluding Charges in Australia

Amid the growing lawsuits and controversy that Pfizer’s Lipitor causes type-2 diabetes in female patients between the ages of 50 and 79 with BMI (Body Mass Index) below 30, (See California coordinated Lipitor cases in Los Angeles Superior Court JCCP no. 4761; In re Lipitor (Atorvastatin) Litigation, MDL No. 2502 (JPML)), Pfizer faces more legal [...]

February 24th, 2014|Drug and Medical Device Litigation, Lipitor|0 Comments